We are live on
!
Find out more
Fate Therapeutics
FATE
FATE
90 hedge funds and large institutions have $385M invested in Fate Therapeutics in 2018 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 35 increasing their positions, 21 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
118% more first-time investments, than exits
New positions opened: 24 | Existing positions closed: 11
111% more call options, than puts
Call options by funds: $1.26M | Put options by funds: $594K
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
78% more capital invested
Capital invested by funds: $216M → $385M (+$169M)
67% more repeat investments, than reductions
Existing positions increased: 35 | Existing positions reduced: 21
15% more funds holding
Funds holding: 78 → 90 (+12)
5.95% more ownership
Funds ownership: 68.75% → 74.69% (+5.9%)
Holders
90
Holders Change
+12
Holders Change %
+15.38%
% of All Funds
2.06%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
24
Increased
35
Reduced
21
Closed
11
Calls
$1.26M
Puts
$594K
Net Calls
+$662K
Net Calls Change
+$624K
Top Buyers
| 1 |
BlackRock
New York
|
+$11.5M |
| 2 |
RG
Redmile Group
San Francisco,
California
|
+$11.4M |
| 3 |
AG
Artal Group
Luxembourg
|
+$8.14M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$4.19M |
| 5 |
JP Morgan Chase
New York
|
+$3.82M |
Top Sellers
| 1 |
ECM
Endurant Capital Management
San Mateo,
California
|
-$3.84M |
| 2 |
Morgan Stanley
New York
|
-$2.8M |
| 3 |
Wells Fargo
San Francisco,
California
|
-$2.14M |
| 4 |
Millennium Management
New York
|
-$2.07M |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
-$1.83M |
